Literature DB >> 23859623

New fluorescent substrate enables quantitative and high-throughput examination of vesicular monoamine transporter 2 (VMAT2).

Gang Hu1, Adam Henke, Richard J Karpowicz, Mark S Sonders, Frances Farrimond, Robert Edwards, David Sulzer, Dalibor Sames.   

Abstract

Vesicular monoamine transporter 2 (VMAT2) is an essential component of the monoaminergic neurotransmission system in the brain as it transports monoamine neurotransmitters from the neuronal cytosol into the synaptic vesicles and thus contributes to modulation of neurotransmitter release. Considering the continuing interest in VMAT2 as a drug target, as well as a target for the design of imaging probes, we have developed a fluorescent substrate well suited for the study of VMAT2 in cell culture. Herein, we report the synthesis and characterization of a new fluorescent probe, FFN206, as an excellent VMAT2 substrate capable of detecting VMAT2 activity in intact cells using fluorescence microscopy, with subcellular localization to VMAT2-expressing acidic compartments without apparent labeling of other organelles. VMAT2 activity can also be measured via microplate reader. The apparent Km of FFN206 at VMAT2 was found to be 1.16 ± 0.10 μM, similar to that of dopamine. We further report the development and validation of a cell-based fluorescence assay amenable to high-throughput screening (HTS) using VMAT2-transfected HEK cells (Z'-factor of 0.7-0.8), enabling rapid identification of VMAT2 inhibitors and measurement of their inhibition constants over a broad range of affinities. FFN206 thus represents a new tool for optical examination of VMAT2 function in cell culture.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23859623      PMCID: PMC4557792          DOI: 10.1021/cb400259n

Source DB:  PubMed          Journal:  ACS Chem Biol        ISSN: 1554-8929            Impact factor:   5.100


  44 in total

1.  A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays.

Authors: 
Journal:  J Biomol Screen       Date:  1999

2.  Validation of a fluorescence-based high-throughput assay for the measurement of neurotransmitter transporter uptake activity.

Authors:  Susanne Jørgensen; Elsebet Østergaard Nielsen; Dan Peters; Tino Dyhring
Journal:  J Neurosci Methods       Date:  2007-12-17       Impact factor: 2.390

3.  Vesicular monoamine transporter concentrations in bipolar disorder type I, schizophrenia, and healthy subjects.

Authors:  J K Zubieta; S F Taylor; P Huguelet; R A Koeppe; M R Kilbourn; K A Frey
Journal:  Biol Psychiatry       Date:  2001-01-15       Impact factor: 13.382

4.  Development of pH-responsive fluorescent false neurotransmitters.

Authors:  Minhee Lee; Niko G Gubernator; David Sulzer; Dalibor Sames
Journal:  J Am Chem Soc       Date:  2010-07-07       Impact factor: 15.419

5.  A nonradioactive high-throughput/high-content assay for measurement of the human serotonin reuptake transporter function in vitro.

Authors:  Ann Fowler; Nicole Seifert; Vincent Acker; Tina Woehrle; Claus Kilpert; Antoine de Saizieu
Journal:  J Biomol Screen       Date:  2006-11-12

6.  PACAP38 increases vesicular monoamine transporter 2 (VMAT2) expression and attenuates methamphetamine toxicity.

Authors:  T S Guillot; J R Richardson; M Z Wang; Y J Li; T N Taylor; B J Ciliax; O Zachrisson; A Mercer; G W Miller
Journal:  Neuropeptides       Date:  2008-06-03       Impact factor: 3.286

7.  The chromaffin granule and synaptic vesicle amine transporters differ in substrate recognition and sensitivity to inhibitors.

Authors:  D Peter; J Jimenez; Y Liu; J Kim; R H Edwards
Journal:  J Biol Chem       Date:  1994-03-11       Impact factor: 5.157

8.  Lobelane inhibits methamphetamine-evoked dopamine release via inhibition of the vesicular monoamine transporter-2.

Authors:  Justin R Nickell; Sairam Krishnamurthy; Seth Norrholm; Gabriela Deaciuc; Kiran B Siripurapu; Guangrong Zheng; Peter A Crooks; Linda P Dwoskin
Journal:  J Pharmacol Exp Ther       Date:  2009-10-23       Impact factor: 4.030

9.  Heterosynaptic dopamine neurotransmission selects sets of corticostriatal terminals.

Authors:  Nigel S Bamford; Hui Zhang; Yvonne Schmitz; Nan-Ping Wu; Carlos Cepeda; Michael S Levine; Claudia Schmauss; Stanislav S Zakharenko; Leonard Zablow; David Sulzer
Journal:  Neuron       Date:  2004-05-27       Impact factor: 17.173

10.  Pt(IV)-catalyzed cyclization of arene-alkyne substrates via intramolecular electrophilic hydroarylation.

Authors:  Stefan J Pastine; So Won Youn; Dalibor Sames
Journal:  Org Lett       Date:  2003-04-03       Impact factor: 6.005

View more
  25 in total

Review 1.  Synaptic optical imaging platforms: Examining pharmacological modulation of neurotransmitter release at discrete synapses.

Authors:  Paolomi Merchant; David Sulzer; Dalibor Sames
Journal:  Neuropharmacology       Date:  2015-03-30       Impact factor: 5.250

Review 2.  The vesicular monoamine transporter 2: an underexplored pharmacological target.

Authors:  Alison I Bernstein; Kristen A Stout; Gary W Miller
Journal:  Neurochem Int       Date:  2014-01-04       Impact factor: 3.921

3.  Drosophila Ptp4E regulates vesicular packaging for monoamine-neuropeptide co-transmission.

Authors:  Juan Tao; Dinara Bulgari; Drew A Berkhoudt; Michael J Calderon; Simon C Watkins; Hector J Fonseca Velez; Nadezhda Sabeva; David L Deitcher; Edwin S Levitan
Journal:  J Cell Sci       Date:  2019-04-03       Impact factor: 5.285

4.  Label-free dopamine imaging in live rat brain slices.

Authors:  Bidyut Sarkar; Arkarup Banerjee; Anand Kant Das; Suman Nag; Sanjeev Kumar Kaushalya; Umakanta Tripathy; Mohammad Shameem; Shubha Shukla; Sudipta Maiti
Journal:  ACS Chem Neurosci       Date:  2014-03-31       Impact factor: 4.418

Review 5.  Current approaches for the discovery of drugs that deter substance and drug abuse.

Authors:  Adam Yasgar; Anton Simeonov
Journal:  Expert Opin Drug Discov       Date:  2014-09-24       Impact factor: 6.098

6.  Neuronal Depolarization Drives Increased Dopamine Synaptic Vesicle Loading via VGLUT.

Authors:  Jenny I Aguilar; Matthew Dunn; Susana Mingote; Caline S Karam; Zachary J Farino; Mark S Sonders; Se Joon Choi; Anna Grygoruk; Yuchao Zhang; Carolina Cela; Ben Jiwon Choi; Jorge Flores; Robin J Freyberg; Brian D McCabe; Eugene V Mosharov; David E Krantz; Jonathan A Javitch; David Sulzer; Dalibor Sames; Stephen Rayport; Zachary Freyberg
Journal:  Neuron       Date:  2017-08-17       Impact factor: 17.173

7.  Toward Serotonin Fluorescent False Neurotransmitters: Development of Fluorescent Dual Serotonin and Vesicular Monoamine Transporter Substrates for Visualizing Serotonin Neurons.

Authors:  Adam Henke; Yekaterina Kovalyova; Matthew Dunn; Dominik Dreier; Niko G Gubernator; Iva Dincheva; Christopher Hwu; Peter Šebej; Mark S Ansorge; David Sulzer; Dalibor Sames
Journal:  ACS Chem Neurosci       Date:  2018-02-02       Impact factor: 4.418

8.  Merkel Cells Activate Sensory Neural Pathways through Adrenergic Synapses.

Authors:  Benjamin U Hoffman; Yoshichika Baba; Theanne N Griffith; Eugene V Mosharov; Seung-Hyun Woo; Daniel D Roybal; Gerard Karsenty; Ardem Patapoutian; David Sulzer; Ellen A Lumpkin
Journal:  Neuron       Date:  2018-11-08       Impact factor: 17.173

9.  Structure-Activity Relationships of Substituted Cathinones, with Transporter Binding, Uptake, and Release.

Authors:  Amy J Eshleman; Katherine M Wolfrum; John F Reed; Sunyoung O Kim; Tracy Swanson; Robert A Johnson; Aaron Janowsky
Journal:  J Pharmacol Exp Ther       Date:  2016-10-31       Impact factor: 4.030

Review 10.  Advances and Challenges in Rational Drug Design for SLCs.

Authors:  Rachel-Ann A Garibsingh; Avner Schlessinger
Journal:  Trends Pharmacol Sci       Date:  2019-09-10       Impact factor: 14.819

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.